Clinical Trial Update: Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study evaluating safety and pharmacokinetics of AVE8062 combined with docetaxel and cisplatin in patients with solid malignant tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasms

Drugs mentioned

• AVE8062
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Neoplasms, Malignant | Phase 1 | Status: COMPLETED